Possible Breast Cancer Risk Related to Background Parenchymal Enhancement at Breast MRI: A Meta-Analysis Study

References

• Uematsu T, Kasami M, Watanabe J. Should breast MRI be performed with adjustment for the phase in patients’ menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients’ menstrual cycle. Eur J Radiol. 2012;81(7):1539–42. doi:10.1016/j.ejrad.2011.04.059
   PubMed Web of Science ®Google Scholar
• D’Orsi C, Bassett L, Feig S. Breast imaging reporting and data system (BI-RADS). Breast imaging atlas. 4th ed. Reston (VA): American College of Radiology; 2018.
   Google Scholar
• King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol. 2012;22(12):2641–7. doi:10.1007/s00330-012-2553-8
   PubMed Web of Science ®Google Scholar
• Mercado CL. BI-RADS update. Radiol Clin North Am. 2014;52(3):481–7. doi:10.1016/j.rcl.2014.02.008
   PubMed Web of Science ®Google Scholar
• Hambly NM, Liberman L, Dershaw DD, Brennan S, Morris EA. Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up. AJR Am J Roentgenol. 2011;196(1):218–24. doi:10.2214/AJR.10.4550
   PubMed Web of Science ®Google Scholar
• DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. Am J Roentgenol. 2012;198(4):W373–80. doi:10.2214/AJR.10.6272
   PubMed Web of Science ®Google Scholar
• van der Velden BHM, Dmitriev I, Loo CE, Pijnappel RM, Gilhuijs KGA. Association between parenchymal enhancement of the contralateral breast in dynamic contrast-enhanced MR imaging and outcome of patients with unilateral invasive breast cancer. Radiology. 2015;276(3):675–85. doi:10.1148/radiol.15142192
   PubMed Web of Science ®Google Scholar
• Oh SJ, Chae EY, Cha JH, Shin HJ, Choi WJ, Kim HH. Relationship between background parenchymal enhancement on breast MRI and pathological tumor response in breast cancer patients receiving neoadjuvant chemotherapy. Br J Radiol. 2018;91(1088):20170550. doi:10.1259/bjr.20170550
   PubMed Web of Science ®Google Scholar
• Freedman AN, Yu B, Gail MH, Costantino JP, Graubard BI, Vogel VG, Anderson GL, McCaskill-Stevens W. Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol. 2011;29(17):2327–33. doi:10.1200/JCO.2010.33.0258
   PubMed Web of Science ®Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000;283(15):2008–12. doi:10.1001/jama.283.15.2008
   PubMed Web of Science ®Google Scholar
• Gupta A, Das A, Majumder K, Arora N, Mayo HG, Singh PP, Beg MS, Singh S. Obesity is independently associated with increased risk of hepatocellular cancer-related mortality: a systematic review and meta-analysis. Am J Clin Oncol. 2018;41(9):874–81. doi:10.1097/COC.0000000000000388
   PubMed Web of Science ®Google Scholar
• Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280–6. doi:10.7326/0003-4819-158-4-201302190-00009
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60. doi:10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Baltzer PA, Dietzel M, Vag T, Burmeister H, Gajda M, Camara O, Pfleiderer SO, Kaiser WA. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. In: RöFo-Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. New York: © Georg Thieme Verlag KG Stuttgart; 2011.
   Google Scholar
• Sippo DA, Rutledge GM, Burk KS, Mercaldo SF, Dontchos BN, Edmonds CE, Lehman CD. Effect of background parenchymal enhancement on cancer risk across different high-risk patient populations undergoing screening breast MRI. Am J Roentgenol. 2019;212(6):1412–8. doi:10.2214/AJR.18.20566
   PubMed Web of Science ®Google Scholar
• Horvat JV, Durando M, Milans S, Patil S, Massler J, Gibbons G, Giri D, Pinker K, Morris EA, Thakur SB, et al. Apparent diffusion coefficient mapping using diffusion-weighted MRI: impact of background parenchymal enhancement, amount of fibroglandular tissue and menopausal status on breast cancer diagnosis. Eur Radiol. 2018;28(6):2516–24. doi:10.1007/s00330-017-5202-4
   PubMed Web of Science ®Google Scholar
• Bennani-Baiti B, Dietzel M, Baltzer PA. MRI background parenchymal enhancement is not associated with breast cancer. PLoS One. 2016;11(7):e0158573. doi:10.1371/journal.pone.0158573
   PubMed Web of Science ®Google Scholar
• Uematsu T, Kasami M, Watanabe J. Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer? Eur Radiol. 2011;21(11):2261–7. doi:10.1007/s00330-011-2175-6
   PubMed Web of Science ®Google Scholar
• Melsaether A, Pujara AC, Elias K, Pysarenko K, Gudi A, Dodelzon K, Babb JS, Gao Y, Moy L. Background parenchymal enhancement over exam time in patients with and without breast cancer. J Magn Reson Imaging. 2017;45(1):74–83. doi:10.1002/jmri.25338
   PubMed Web of Science ®Google Scholar
• Cho GY, Moy L, Kim SG, Klautau Leite AP, Baete SH, Babb JS, Sodickson DK, Sigmund EE. Comparison of contrast enhancement and diffusion-weighted magnetic resonance imaging in healthy and cancerous breast tissue. Eur J Radiol. 2015;84(10):1888–93. doi:10.1016/j.ejrad.2015.06.023
   PubMed Web of Science ®Google Scholar
• DeLeo MJ, Domchek SM, Kontos D, Conant E, Chen J, Weinstein S. Breast MRI fibroglandular volume and parenchymal enhancement in BRCA1 and BRCA2 mutation carriers before and immediately after risk-reducing salpingo-oophorectomy. AJR Am J Roentgenol. 2015;204(3):669–73. doi:10.2214/AJR.13.12146
   PubMed Web of Science ®Google Scholar
• Albert M, Schnabel F, Chun J, Schwartz S, Lee J, Klautau Leite AP, Moy L. The relationship of breast density in mammography and magnetic resonance imaging in high-risk women and women with breast cancer. Clin Imaging. 2015;39(6):987–92. doi:10.1016/j.clinimag.2015.08.001
   PubMed Web of Science ®Google Scholar
• Dontchos BN, Rahbar H, Partridge SC, Korde LA, Lam DL, Scheel JR, Peacock S, Lehman CD. Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk? Radiology. 2015;276(2):371–80. doi:10.1148/radiol.2015142304
   PubMed Web of Science ®Google Scholar
• King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology. 2011;260(1):50–60. doi:10.1148/radiol.11102156
   PubMed Web of Science ®Google Scholar
• Price ER, Brooks JD, Watson EJ, Brennan SB, Comen EA, Morris EA. The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue. Eur Radiol. 2014;24(1):162–8. doi:10.1007/s00330-013-2993-9
   PubMed Web of Science ®Google Scholar
• Wu S, Weinstein SP, DeLeo MJ, Conant EF, Chen J, Domchek SM, Kontos D. Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers. Breast Cancer Res. 2015;17(1):67. doi:10.1186/s13058-015-0577-0
   PubMed Web of Science ®Google Scholar
• Hu X, Jiang L, Li Q, Gu Y. Quantitative assessment of background parenchymal enhancement in breast magnetic resonance images predicts the risk of breast cancer. Oncotarget. 2017;8(6):10620–7. doi:10.18632/oncotarget.13538
   PubMedGoogle Scholar
• Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G, Moschetta M. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer. Magn Reson Imaging. 2016;34(2):173–6. doi:10.1016/j.mri.2015.10.014
   PubMed Web of Science ®Google Scholar
• Wu S, Zuley ML, Berg WA, Kurland BF, Jankowitz RC, Sumkin JH, Gur D. DCE-MRI background parenchymal enhancement quantified from an early versus delayed post-contrast sequence: association with breast cancer presence. Sci Rep. 2017;7(1):2115. doi:10.1038/s41598-017-02341-8
   PubMed Web of Science ®Google Scholar
• Grimm LJ, Saha A, Ghate SV, Kim C, Soo MS, Yoon SC, Mazurowski MA. Relationship between background parenchymal enhancement on high-risk screening MRI and future breast cancer risk. Acad Radiol. 2019;26(1):69–75. doi:10.1016/j.acra.2018.03.013
   PubMed Web of Science ®Google Scholar